BioWorld

May 24, 2006

Pharmacopeia Rises On Deal With Cephalon: $15M Up Front

Shares of Pharmacopeia Drug Discovery Inc. jumped 26.3 percent after the company signed a drug discovery deal with Cephalon Inc. that includes a $15 million up-front fee and the potential for double-digit royalties. (BioWorld Today) Read More

Avanir Buys Alamo, Gains CNS Product, Sales Force

New River Starts Phase III Study For NRP104 Against Adult ADHD

BioWorld Releases First Report On Top 25 Biotechnology Drugs

Hold On Avastin Study Lifted After 60-Day Review By DSMB

Clinic Roundup

Other News To Note

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for June 5, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 2, 2026

Janssen Pharmaceutica reports new TMEM175 activators

BioWorld Science

Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...

Cancer specter looming, Abtect effect in UC wallops Abivax

BioWorld

Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...

EASL spotlight: TUNE-401 advances epigenetic silencing in HBV

BioWorld

Several presentations at EASL highlight a new generation of therapies coming into view, with the work from Tune Therapeutics Inc. standing out as one of the most...